Danesi R - Search Results

1

The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide.

Del Re M, Fogli S, Derosa L, Massari F, De Souza P, Crucitta S, Bracarda S, Santini D, Danesi R. Del Re M, et al. Among authors: danesi r. Cancer Treat Rev. 2017 Apr;55:71-82. doi: 10.1016/j.ctrv.2017.03.001. Epub 2017 Mar 9. Cancer Treat Rev. 2017. PMID: 28340451 Review.

2

Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo.

Bocci G, Danesi R, Benelli U, Innocenti F, Di Paolo A, Fogli S, Del Tacca M. Bocci G, et al. Among authors: danesi r. Cancer Chemother Pharmacol. 1999;43(3):205-12. doi: 10.1007/s002800050885. Cancer Chemother Pharmacol. 1999. PMID: 9923550

3

Metabolism of 6-mercaptopurine in the erythrocytes, liver, and kidney of rats during multiple-dose regimens.

Innocenti F, Danesi R, Bocci G, Fogli S, Di Paolo A, Del Tacca M. Innocenti F, et al. Among authors: danesi r. Cancer Chemother Pharmacol. 1999;43(2):133-40. doi: 10.1007/s002800050873. Cancer Chemother Pharmacol. 1999. PMID: 9923818

4

An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma.

Fogli S, Danesi R, Innocenti F, Di Paolo A, Bocci G, Barbara C, Del Tacca M. Fogli S, et al. Among authors: danesi r. Ther Drug Monit. 1999 Jun;21(3):367-75. doi: 10.1097/00007691-199906000-00022. Ther Drug Monit. 1999. PMID: 10365655 Clinical Trial.

5

The gemcitabine/epirubicin/paclitaxel combination in advanced breast cancer.

Gennari A, Donati S, Danesi R, Fogli S, Orlandini C, Del Tacca M, Conte PF. Gennari A, et al. Among authors: danesi r. Semin Oncol. 2000 Feb;27(1 Suppl 2):14-9. Semin Oncol. 2000. PMID: 10697031 Clinical Trial.

6

Manumycin inhibits ras signal transduction pathway and induces apoptosis in COLO320-DM human colon tumour cells.

Di Paolo A, Danesi R, Nardini D, Bocci G, Innocenti F, Fogli S, Barachini S, Marchetti A, Bevilacqua G, Del Tacca M. Di Paolo A, et al. Among authors: danesi r. Br J Cancer. 2000 Feb;82(4):905-12. doi: 10.1054/bjoc.1999.1018. Br J Cancer. 2000. PMID: 10732765 Free PMC article.

7

Variable correlation between 6-mercaptopurine metabolites in erythrocytes and hematologic toxicity: implications for drug monitoring in children with acute lymphoblastic leukemia.

Innocenti F, Danesi R, Favre C, Nardi M, Menconi MC, Di Paolo A, Bocci G, Fogli S, Barbara C, Barachini S, Casazza G, Macchia P, Del Tacca M. Innocenti F, et al. Among authors: danesi r. Ther Drug Monit. 2000 Aug;22(4):375-82. doi: 10.1097/00007691-200008000-00002. Ther Drug Monit. 2000. PMID: 10942174

8

Pharmacogenetic determinants of anti-cancer drug activity and toxicity.

Danesi R, De Braud F, Fogli S, Di Paolo A, Del Tacca M. Danesi R, et al. Trends Pharmacol Sci. 2001 Aug;22(8):420-6. doi: 10.1016/s0165-6147(00)01742-9. Trends Pharmacol Sci. 2001. PMID: 11479005 Review.

9

Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study.

Conte PF, Gennari A, Donati S, Salvadori B, Baldini E, Bengala C, Pazzagli I, Orlandini C, Danesi R, Fogli S, Del Tacca M. Conte PF, et al. Among authors: danesi r. Breast Cancer Res Treat. 2001 Jul;68(2):171-9. doi: 10.1023/a:1011945623464. Breast Cancer Res Treat. 2001. PMID: 11688520 Clinical Trial.

10

Design, synthesis, and characterization of the antitumor activity of novel ceramide analogues.

Macchia M, Barontini S, Bertini S, Di Bussolo V, Fogli S, Giovannetti E, Grossi E, Minutolo F, Danesi R. Macchia M, et al. Among authors: danesi r. J Med Chem. 2001 Nov 8;44(23):3994-4000. doi: 10.1021/jm010947r. J Med Chem. 2001. PMID: 11689086

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

525 results

Search Page

Filters